Böttcher, Sebastian http://orcid.org/0000-0002-3407-8290
Vieluf, Solveig http://orcid.org/0000-0002-5532-8690
Bruno, Elisa http://orcid.org/0000-0001-8166-1190
Joseph, Boney http://orcid.org/0000-0002-1576-9344
Epitashvili, Nino http://orcid.org/0000-0003-2765-8286
Biondi, Andrea http://orcid.org/0000-0003-1072-665X
Zabler, Nicolas http://orcid.org/0000-0002-4406-1863
Glasstetter, Martin http://orcid.org/0000-0002-4929-4332
Dümpelmann, Matthias http://orcid.org/0000-0002-1476-7777
Van Laerhoven, Kristof http://orcid.org/0000-0001-5296-5347
Nasseri, Mona http://orcid.org/0000-0002-2511-1458
Brinkman, Benjamin H. http://orcid.org/0000-0002-2392-8608
Richardson, Mark P. http://orcid.org/0000-0001-8925-3140
Schulze-Bonhage, Andreas http://orcid.org/0000-0003-2382-0506
Loddenkemper, Tobias http://orcid.org/0000-0003-2074-0674
Funding for this research was provided by:
Innovative Medicines Initiative (115902)
Deutsche Forschungsgemeinschaft (VI 1088/1-1)
Epilepsy Foundation (My Seizure Gauge)
Mayo Clinic
Epilepsy Research UK
National Institutes of Health (UG3 NS123066)
National Science Foundation (CBET-2138378)
Epilepsy Research Fund
Universitätsklinikum Freiburg
Article History
Received: 15 September 2022
Accepted: 25 November 2022
First Online: 10 December 2022
Competing interests
: T.L. is part of patent applications to detect and predict clinical outcomes and to manage, diagnose, and treat neurological conditions, epilepsy, and seizures. T.L. received past device donations from various companies, including Empatica, and has received research support from Empatica in the past. S.V. and T.L. are part of a patent application covering technology for seizure forecasting that includes this work. B.B. reports receiving device donations from Medtronic Inc., research support from UNEEG and Seer Medical Pty, and licensed IP to Cadence Neuroscience. B.B. is also a named inventor on patent applications for seizure detection and forecasting with wearable devices. M.R. is a named inventor on a patent to assess susceptibility to seizures from EEG (WO2013182848A1) and is named in a patent application for seizure forecasting. A.S.-B. has received research support from UNEEG. Other authors report no other relevant disclosures.